What is Thriva?
Thriva operates at the intersection of consumer health and diagnostic technology, providing a sophisticated platform that enables users to monitor internal blood markers from the comfort of their homes. By utilizing a simple finger-prick testing mechanism, the company bridges the gap between clinical-grade laboratory analysis and consumer accessibility. This model allows individuals to track health trends over time, offering actionable insights that empower proactive wellness management. Headquartered in London, Thriva has positioned itself as a key player in the personalized medicine space, leveraging data-driven diagnostics to improve health outcomes and reduce the friction typically associated with traditional medical testing services.
How much funding has Thriva raised?
Thriva has raised a total of $15.5M across 2 funding rounds:
Angel/Seed
$1.9M
Series A
$13.6M
Angel/Seed (2017): $1.9M with participation from 500.com, Seedcamp, and London Co-Investment Fund
Series A (2019): $13.6M led by Pembroke VCT, GAM Investments, and Target Global
Key Investors in Thriva
Target Global
A pan-European technology investment firm managing over 3 billion in assets, focusing on high-growth companies from pre-seed to pre-IPO stages.
Seedcamp
A prominent venture capital firm specializing in early-stage startups, providing mentorship and access to a global network for ambitious founders.
London Co-Investment Fund
A public-private venture capital fund backed by the London Mayor's office, dedicated to supporting innovative, high-growth startups based in London.
What's next for Thriva?
With the successful closure of its latest financing round, Thriva is well-positioned to scale its operations and expand its market footprint. The strategic focus moving forward will likely involve enhancing the platform's diagnostic breadth, refining the user experience, and strengthening its integration with broader healthcare ecosystems. As the company transitions from a high-growth startup to a more mature enterprise, the focus will shift toward operational efficiency and the continued development of its proprietary health-tracking software. By leveraging the expertise of its diverse investor base, Thriva aims to solidify its leadership in the digital health sector, ultimately driving the adoption of preventative, data-centric health monitoring on a global scale.
See full Thriva company page
